Ignite Creation Date:
2025-12-25 @ 5:01 AM
Ignite Modification Date:
2026-05-07 @ 9:46 AM
Study NCT ID:
NCT00752518
Status:
COMPLETED
Last Update Posted:
2011-05-17
First Post:
2008-09-11
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Japan Phase I/II Study of Bortezomib in Relapsed or Refractory Multiple Myeloma Patients
Sponsor:
Organization:
Study Design
Study Type:
INTERVENTIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
None
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
Enrollment Type:
Design Primary Purpose:
Design Masking:
Time Perspective List:
Who Masked List: